logo

Pultegroup, Inc. (PHM)



Trade PHM now with
  Date
  Headline
4/13/2020 11:56:18 AM Wedbush Is Cutting PulteGroup, Inc. (PHM) 4Q21 Rev. Estimate To 2881.3 M From 3459.4 M
4/13/2020 11:56:04 AM Wedbush Is Lowering PulteGroup, Inc. (PHM) 3Q21 Rev. Estimate To 2706.2 M From 3115.8 M
4/13/2020 11:55:42 AM Wedbush Is Cutting PulteGroup, Inc. (PHM) 2Q21 Rev. Estimate To 2592.2 M From 2807.8 M
4/13/2020 11:55:23 AM Wedbush Is Cutting PulteGroup, Inc. (PHM) 1Q21 Rev. Estimate To 2186.6 M From 2443.3 M
4/13/2020 11:54:48 AM Wedbush Is Cutting PulteGroup, Inc. (PHM) 2020 Rev. Estimate To 9.66 Billion From 11.19 Billion
4/13/2020 11:54:12 AM Wedbush Is Lowering PulteGroup, Inc. (PHM) 4Q20 Rev. Estimate To 2675.6 M From 3165.8 M
4/13/2020 11:53:45 AM Wedbush Is Lowering PulteGroup, Inc. (PHM) 3Q20 Rev. Estimate To 2256.2 M From 2968.8 M
4/13/2020 11:53:20 AM Wedbush Is Lowering PulteGroup, Inc. (PHM) 2Q20 Rev. Estimate To 2413.8 M From 2738.5 M
2/19/2020 8:06:18 AM PulteGroup Sharing Its Top Trends To Look For In 2020
2/17/2020 2:33:42 AM PharmaMar And Jazz Pharma Announce FDA Acceptance And Priority Review Of NDA For Lurbinectedin
2/6/2020 12:14:01 PM PulteGroup, Inc. (PHM) Declares Quarterly Dividend of $ 0.12, Record Date 3/13/2020
2/6/2020 10:02:40 AM PulteGroup Declares Dividend Of $0.12/shr; Payable April 3/record March 13
1/28/2020 6:34:27 AM PulteGroup Acquires Innovative Construction Group; Terms Not Disclosed
1/28/2020 6:34:16 AM PulteGroup Q4 Adj. EPS $1.14, Consensus $1.09
1/22/2020 2:40:10 AM PharmaMar, Jazz U.S. License Agreement For Lurbinectedin Effective With Expiration Of HSR Waiting Period